R. Kirk Huntsman
2021
In 2021, R. Kirk Huntsman earned a total compensation of $1.1M as Chief Executive Officer at Vivos Therapeutics, a 137% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $144,318 |
|---|---|
| Option Awards | $570,300 |
| Salary | $344,229 |
| Other | $18,302 |
| Total | $1,077,149 |
Huntsman received $570.3K in option awards, accounting for 53% of the total pay in 2021.
Huntsman also received $144.3K in non-equity incentive plan, $344.2K in salary and $18.3K in other compensation.
Rankings
In 2021, R. Kirk Huntsman's compensation ranked 8,535th out of 12,406 executives tracked by ExecPay. In other words, Huntsman earned more than 31.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,535 out of 12,406 | 31st |
Division Manufacturing | 3,783 out of 5,494 | 31st |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 482 out of 798 | 40th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 304 out of 519 | 41st |
Industry Surgical and Medical Instruments and Apparatus | 194 out of 324 | 40th |
Source: SEC filing on July 14, 2022.
Huntsman's colleagues
We found two more compensation records of executives who worked with R. Kirk Huntsman at Vivos Therapeutics in 2021.